JP2018536628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018536628A5 JP2018536628A5 JP2018516418A JP2018516418A JP2018536628A5 JP 2018536628 A5 JP2018536628 A5 JP 2018536628A5 JP 2018516418 A JP2018516418 A JP 2018516418A JP 2018516418 A JP2018516418 A JP 2018516418A JP 2018536628 A5 JP2018536628 A5 JP 2018536628A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- antibody
- antigen
- binding portion
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562238680P | 2015-10-07 | 2015-10-07 | |
| US62/238,680 | 2015-10-07 | ||
| PCT/US2016/056032 WO2017062792A1 (en) | 2015-10-07 | 2016-10-07 | Novel carbohydrate antibodies, pharmaceutical compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018536628A JP2018536628A (ja) | 2018-12-13 |
| JP2018536628A5 true JP2018536628A5 (enExample) | 2019-10-17 |
Family
ID=58488607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018516418A Pending JP2018536628A (ja) | 2015-10-07 | 2016-10-07 | 新規炭水化物抗体、医薬組成物およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10501532B2 (enExample) |
| EP (1) | EP3359193A4 (enExample) |
| JP (1) | JP2018536628A (enExample) |
| KR (1) | KR20180077181A (enExample) |
| CN (1) | CN108472362B (enExample) |
| AR (1) | AR106307A1 (enExample) |
| AU (1) | AU2016335842A1 (enExample) |
| BR (1) | BR112018006140A2 (enExample) |
| CA (1) | CA3000531A1 (enExample) |
| IL (1) | IL257956A (enExample) |
| TW (1) | TWI704159B (enExample) |
| WO (1) | WO2017062792A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201510740YA (en) | 2013-09-17 | 2016-01-28 | Obi Pharma Inc | Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment |
| JP2018532990A (ja) | 2015-09-04 | 2018-11-08 | オービーアイ ファーマ，インコーポレイテッド | グリカンアレイおよび使用の方法 |
| TWI780045B (zh) | 2016-03-29 | 2022-10-11 | 台灣浩鼎生技股份有限公司 | 抗體、醫藥組合物及方法 |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| AU2017252128B2 (en) | 2016-04-22 | 2024-06-06 | Obi Pharma, Inc. | Cancer immunotherapy by immune activation or immune modulation via Globo series antigens |
| KR20230117482A (ko) | 2016-07-27 | 2023-08-08 | 오비아이 파머 인코퍼레이티드 | 면역원성/치료 글리칸 조성물 및 그의 용도 |
| JP7121724B2 (ja) | 2016-07-29 | 2022-08-18 | オービーアイ ファーマ，インコーポレイテッド | ヒト抗体、医薬組成物及び方法 |
| WO2018094414A1 (en) | 2016-11-21 | 2018-05-24 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| CA3064443A1 (en) * | 2017-05-24 | 2018-11-29 | Development Center For Biotechnology | Humanized antibodies against globo h and uses thereof in cancer treatments |
| IL277174B2 (en) * | 2018-03-13 | 2025-12-01 | Hoffmann La Roche | Therapeutic combination of 4-1 bb agonists with anti-cd20 antibodies |
| KR20210031651A (ko) * | 2018-06-01 | 2021-03-22 | 오비아이 파머 인코퍼레이티드 | 항-음성 면역 관문 항체와 항-globo h 또는 항-ssea-4 항체를 사용한 병용 요법 |
| TWI853822B (zh) | 2018-06-27 | 2024-09-01 | 台灣浩鼎生技股份有限公司 | 用於糖蛋白工程的糖苷合成酶變體及其使用方法 |
| GB201910899D0 (en) * | 2019-07-31 | 2019-09-11 | Scancell Ltd | Binding members |
| CN116589572B (zh) * | 2023-06-28 | 2023-11-10 | 湖南诺合新生物科技有限公司 | 一种抗ha标签的单克隆抗体及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| JPS63501765A (ja) | 1985-11-01 | 1988-07-21 | インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド | 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途 |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| BR0107262B1 (pt) | 2001-12-17 | 2014-04-22 | Da Fonseca Clovis Orlando Pereira | Composição farmacêutica inalatória |
| EP1646655A2 (en) * | 2003-07-09 | 2006-04-19 | Eli Lilly And Company | Tgf-beta1 ligands |
| CA2595906C (en) * | 2005-02-01 | 2014-04-22 | Dyax Corp. | Libraries and methods for isolating antibodies |
| US20100082438A1 (en) | 2008-10-01 | 2010-04-01 | Ronnie Jack Garmon | Methods and systems for customer performance scoring |
| TWI583393B (zh) * | 2009-06-16 | 2017-05-21 | 中央研究院 | 免疫原性組合物、包含其之疫苗與治療劑及其用途 |
| BR112012025730B1 (pt) | 2010-04-09 | 2020-12-08 | Aveo Pharmaceuticals, Inc | anticorpo isolado que se liga ao erbb3 humano, seus usos, seu processo de produção e vetor de expressão |
| JP6293659B2 (ja) * | 2011-07-01 | 2018-03-14 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 抗プロペルジン抗体およびその使用 |
| WO2015015629A1 (ja) | 2013-08-02 | 2015-02-05 | 株式会社日立製作所 | 炭化珪素半導体装置および炭化珪素半導体装置の製造方法 |
| CN104693305A (zh) * | 2013-12-04 | 2015-06-10 | 苏州中赢医疗科技有限公司 | 一种抗人鞘糖脂Globo-H单克隆抗体、其制备方法及应用 |
| KR20170003912A (ko) | 2014-03-19 | 2017-01-10 | 매카이 메디컬 파운데이션 더 프레즈비티리언 처치 인 타이완 매카이 메모리얼 호스피탈 | 면역원성 당펩타이드에 대한 항체, 이를 포함하는 조성물 및 이의 용도 |
| EP3662928A1 (en) | 2014-04-10 | 2020-06-10 | OBI Pharma Inc. | Antibodies binding to tumour associated carbohydrate antigens, pharmaceutical compositions and uses thereof |
-
2016
- 2016-10-07 CN CN201680056209.7A patent/CN108472362B/zh active Active
- 2016-10-07 TW TW105132620A patent/TWI704159B/zh active
- 2016-10-07 CA CA3000531A patent/CA3000531A1/en not_active Abandoned
- 2016-10-07 US US15/288,562 patent/US10501532B2/en active Active
- 2016-10-07 KR KR1020187012974A patent/KR20180077181A/ko not_active Withdrawn
- 2016-10-07 AR ARP160103089A patent/AR106307A1/es unknown
- 2016-10-07 BR BR112018006140A patent/BR112018006140A2/pt not_active IP Right Cessation
- 2016-10-07 AU AU2016335842A patent/AU2016335842A1/en not_active Abandoned
- 2016-10-07 WO PCT/US2016/056032 patent/WO2017062792A1/en not_active Ceased
- 2016-10-07 JP JP2018516418A patent/JP2018536628A/ja active Pending
- 2016-10-07 EP EP16854440.1A patent/EP3359193A4/en not_active Withdrawn
-
2018
- 2018-03-07 IL IL257956A patent/IL257956A/en unknown
-
2019
- 2019-08-21 US US16/547,009 patent/US11236154B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018536628A5 (enExample) | ||
| EA202091590A1 (ru) | Антитела против pd-l1 и варианты их применения | |
| JP2020536888A5 (enExample) | ||
| IL308807B2 (en) | Combination therapy for treating cancer | |
| HRP20201219T1 (hr) | Anti-vla-4 antitijela | |
| JP2018501197A5 (enExample) | ||
| GEP20115324B (en) | Tweak binding antibodies | |
| JP2016521688A5 (enExample) | ||
| FI3389699T3 (fi) | Kimeerisiä ja humanisoituja humaaneja monoklonaalisia ctla4-vasta-aineita ja niiden käyttötapoja | |
| EA201000207A1 (ru) | Новые иммуногенные эпитопы для иммунотерапии | |
| JP2017149720A5 (enExample) | ||
| JP2015506912A5 (enExample) | ||
| EA201100228A1 (ru) | Структурные варианты антител для улучшения терапевтических характеристик | |
| JP2019535763A5 (enExample) | ||
| EA201391789A1 (ru) | TNF-АЛЬФА АНТИГЕНСВЯЗЫВАЮЩИЕ БЕЛКИ, ОБЛАДАЮЩИЕ ПОВЫШЕННЫМ СВЯЗЫВАНИЕМ FcRn | |
| MX2021001143A (es) | Anticuerpo de union a il-4r humana, fragmento de union a antigeno y uso medico del mismo. | |
| CY1111337T1 (el) | Βελτιωμενα επιλεκτικα πρωτοϊνιδιων αντισωματα και η χρηση αυτων | |
| JP2015520758A5 (enExample) | ||
| EA200702053A1 (ru) | Антитела против cd38 для лечения множественной миеломы | |
| RU2017145268A (ru) | Композиции и способы диагностики и лечения заболеваний, ассоциированных с дегенерацией нейритов | |
| PH12020552235A1 (en) | Anti-cd40 antibodies for use in treating autoimmune disease | |
| JP2017529097A5 (enExample) | ||
| JP2016094424A5 (enExample) | ||
| JP2017508475A5 (enExample) | ||
| RU2017132827A (ru) | Антитело к notch4 человека |